Refine Search
(19)
(29)
(84)
(202)

Central Nervous System

GlobalData provides unique and market-leading data and insights into the central nervous system market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Post-Traumatic Stress Disorder (PTSD): Opportunity Analysis and Forecasts to 2028

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

Post-traumatic stress disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent per...

Post-Traumatic Stress Disorder: Epidemiology Forecast to 2028

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent per...

Spinal Muscular Atrophy (SMA): Opportunity Analysis and Forecasts to 2028

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

SMA is an area that is expected to witness strong growth in the future, primarily due to launch of pipeline products that are expected to gradually capture market share from Biogen’s Spinraza. Also, the launch of survival motor neuron (SMN)- in...

Spinal Muscular Atrophy: Epidemiology Forecast to 2028

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. The most common form of SMA ...

Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dysgeusia (Taste Disorders) Global Clinical Trials Review, H1, 2019" provides an overview of Dysgeusia (Taste Disorders) clinical trials scenario. This report provides top line data relating to the ...

Dyskinesia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dyskinesia Global Clinical Trials Review, H1, 2019" provides an overview of Dyskinesia clinical trials scenario. This report provides top line data relating to the clinical trials on Dyskinesia. Rep...

Dysautonomia (Autonomic Dysfunction/Autonomic Neuropathy) Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dysautonomia (Autonomic Dysfunction/Autonomic Neuropathy) Global Clinical Trials Review, H1, 2019" provides an overview of Dysautonomia (Autonomic Dysfunction/Autonomic Neuropathy) clinical trials s...

Encephalitis Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, H1, 2019" provides an overview of Encephalitis clinical trials scenario. This report provides top line data relating to the clinical trials on Encephaliti...

Encephalomyelitis Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Encephalomyelitis Global Clinical Trials Review, H1, 2019" provides an overview of Encephalomyelitis clinical trials scenario. This report provides top line data relating to the clinical trials on E...

Encephalopathy Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Encephalopathy Global Clinical Trials Review, H1, 2019" provides an overview of Encephalopathy clinical trials scenario. This report provides top line data relating to the clinical trials on Encepha...

Dysthymia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dysthymia Global Clinical Trials Review, H1, 2019" provides an overview of Dysthymia clinical trials scenario. This report provides top line data relating to the clinical trials on Dysthymia. Report...

Dystonia Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dystonia Global Clinical Trials Review, H1, 2019" provides an overview of Dystonia clinical trials scenario. This report provides top line data relating to the clinical trials on Dystonia. Report in...

Parkinson’s Disease and Behavioral Complications: PD Therapies Dominate First-in-Class Pipeline, with Novel Target Classes Demonstrating Potential Disease-Modifying Effects

  • $6,995
  • May 2019
Add to Basket Quick View Add to Saved List

Parkinson’s disease (PD), a progressive neurological disorder that affects movement control, is associated with considerable quality of life impairments and burden of care, particularly in the advanced disease stages. Cognitive and behavioral c...

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2019" provides an overview of Diabetic Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clin...

Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) Global Clinical Trials Review, H1, 2019" provides an overview of Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy) clinical trials scenari...

Join our mailing list
Find out first about the latest reports and offers.